Associations between inflammatory markers and cognitive function in breast cancer patients receiving chemotherapy
- 14 January 2018
- journal article
- research article
- Published by Elsevier BV in Journal of Neuroimmunology
- Vol. 314, 17-23
- https://doi.org/10.1016/j.jneuroim.2017.10.005
Abstract
No abstract availableKeywords
Funding Information
- NIH (DP2CA195765, F99CA222742, K07CA168886, UG1 CA189961)
This publication has 29 references indexed in Scilit:
- Prevalence, mechanisms, and management of cancer-related cognitive impairmentInternational Review of Psychiatry, 2014
- Impact of perceived cognitive impairment in breast cancer survivorsEuropean Journal of Oncology Nursing, 2013
- The impact of cancer therapy on cognition in the elderlyFrontiers in Pharmacology, 2013
- Neuropsychological Performance in Survivors of Breast Cancer More Than 20 Years After Adjuvant ChemotherapyJournal of Clinical Oncology, 2012
- Cognitive and Psychological Factors Associated with Early Posttreatment Functional Outcomes in Breast Cancer SurvivorsJournal of Psychosocial Oncology, 2009
- Bone lead levels are associated with measures of memory impairment in older adultsNeuroToxicology, 2009
- Evidence for a cytokine model of cognitive functionNeuroscience & Biobehavioral Reviews, 2009
- Proinflammatory Cytokines and Sickness Behavior: Implications for Depression and Cancer-Related SymptomsOncology Nursing Forum, 2008
- Cytokines and Cognition—The Case for A Head‐to‐Toe Inflammatory ParadigmJournal of the American Geriatrics Society, 2002
- Assessing symptom distress in cancer patientsCancer, 2000